Skip to the shortlist
Peptide ClarityGuide
Comparison

NMN or NR: how the two NAD+ precursors compare on evidence and status

Two vitamin B3 supplements, one shared promise, and finally a trial that tested them side by side. Here's what it found and where each one still has gaps.

Peptide Clarity Guide

Heads up: Peptide Clarity Guide works with affiliate partners. Nothing on this page earns us a fee, and the order here ignores who's a partner. How we earn.

The short answer

Neither has been shown to slow aging. In the one head-to-head human trial (2026, 65 adults, 14 days), NMN and NR raised blood NAD+ by similar amounts. NR has a longer US regulatory record; NMN was cleared again for supplements in 2025. On the NAD+ number itself, they tied.

Key takeaways

  • Neither NMN nor NR has been shown to slow aging in people.
  • In the first head-to-head trial (2026, 65 adults, 14 days), both raised blood NAD+ by similar amounts.
  • That trial was open-label and run by Nestlé employees, so treat it as a strong first look, not the last word.
  • NR has the longer US regulatory record; NMN was cleared again for supplements in September 2025.
  • Neither needs a prescription, and no telehealth program in this guide sells either one.

The short version: if you're picking between NMN and NR to raise NAD+, the strongest evidence so far says it's close to a coin flip [1]. Neither is proven to make you live longer or feel younger. What differs is the regulatory history and how much each has been studied. For the NMN basics, start with what NMN is.

Pick by what matters to you, because the NAD+ result was a tie

  • Pick NR if you want the ingredient with the longer US track record and a 2016 FDA "no questions" letter behind its use in foods [8].
  • Pick NMN if you're drawn to its newer trials in older adults and don't mind its bumpier US history [9].
  • Skip both if you're hoping for a proven anti-aging effect. That evidence doesn't exist for either one.
NMN and NR side by side: published human evidence and US status
NMNNR
What it isNicotinamide mononucleotide, a vitamin B3 formNicotinamide riboside, a vitamin B3 form
Head-to-head trial (2026)Raised blood NAD+ [1]Raised blood NAD+ by a comparable amount [1]
Example human trialsYoshino 2021, Yi 2023, Morifuji 2024, Pencina 2023 [4] [5] [6] [7]Martens 2018, Dollerup 2018 [2] [3]
Function benefit shown?Small and mixed; often secondary resultsNot for insulin sensitivity; blood pressure flagged for future trials
US statusAllowed in supplements again since September 29, 2025, after FDA's 2022 exclusion [9]FDA had "no questions" about its GRAS status for use in foods, August 3, 2016 [8]
Prescription needed?NoNo

Both are B3 forms, and gut microbes may do part of the work

NAD+ is a helper molecule your cells use for energy metabolism and repair. Levels fall with age, which is why precursors like NMN and NR sell. Both are forms of vitamin B3 that the body can turn into NAD+.

The 2026 trial added a twist. In lab tests with human gut bacteria, both NMN and NR were converted into nicotinic acid, another B3 form, which then raised NAD+ strongly [1]. If that holds up, the route each one takes through your gut may matter more than their chemistry on paper.

The first head-to-head trial: a tie on NAD+, with caveats

Until 2026, no study had compared NMN and NR directly in people. Many pages still say so. That changed with a randomized, placebo-controlled trial in 65 healthy adults [1].

  • What they compared: NR, NMN, nicotinamide and placebo for 14 days.
  • What happened: NR and NMN "comparably" raised NAD+ in the blood. Nicotinamide didn't, over the 14 days.
  • Who ran it: the authors were employees of Nestlé Research, Nestlé Health Science and a contract lab [1].

On their own, both raise NAD+, and neither shows a clear payoff

NR. In a 2018 crossover trial of healthy middle-aged and older adults, NR was well tolerated and raised NAD+ metabolism; the authors suggested future trials look at blood pressure and artery stiffness [2]. In 40 men with obesity, 12 weeks of NR didn't improve insulin sensitivity, glucose handling or body composition, and caused no serious side effects [3].

NMN. A 10-week trial in postmenopausal women with prediabetes found better muscle insulin sensitivity [4]. In 80 healthy middle-aged adults, NMN raised blood NAD over 60 days and improved walking distance, but not insulin resistance [5]. In 60 older adults, the main physical test didn't change [6].

What the solo trials measured
OutcomeNMNNR
Raises blood NAD+Yes, in several trialsYes
Insulin sensitivityUp in one trial of women with prediabetes; no change in anotherNo change in men with obesity
Physical functionMixed: walking distance up in one trial, main test unchanged in anotherNot shown
Safety over weeksNo safety issues in short trialsWell tolerated; no serious events
Aging or lifespanNot testedNot tested

Several NMN trials were sponsor-run or had sponsor-affiliated authors. For the full NMN picture, see does NMN work and is NMN safe.

NR's US record is steadier; NMN's flipped twice

US regulatory milestones
DateNMNNR
August 3, 2016FDA says it has "no questions" about ChromaDex's conclusion that NR is GRAS for use in foods such as vitamin waters and nutrition bars [8]
2022FDA takes the position that NMN can't be sold as a supplement because it was studied as a drug first [9]
September 29, 2025FDA reverses course and responds to industry petitions that NMN isn't excluded from supplements [9]

A GRAS letter covers use in foods; it isn't an approval, and FDA said it hadn't made its own GRAS determination. NMN still needs the usual new-dietary-ingredient notice from each maker.

Neither is an FDA-approved drug, and supplements can't claim to treat disease. Full NMN history lives on the NMN page.

If you buy one, check the label, not the hype

Both are sold as supplements, so FDA doesn't review each product before it hits the shelf. That puts the checking on you. A few habits help, whichever one you pick:

  • Look for a third-party testing seal that confirms the bottle holds what the label says.
  • Be wary of disease claims. A supplement can't legally claim to treat or prevent a disease, so "reverses aging" is a red flag about the seller, not a feature.
  • Tell your doctor or pharmacist if you take prescription medicines. They can check it against what you already take.
  • Give it a fair test window and know what you're watching for. Most trials ran two to twelve weeks and measured blood markers you can't feel.

One more thing to know: neither one needs a telehealth visit. If a program bundles NMN or NR into a prescription plan, you're paying for the visit, not for access.

Taking both: untested

No trial has tested NMN and NR together. If you're weighing a combo, read can you take NR and NMN together first. Stacking NMN with NAD+ itself is a separate question, covered in NMN and NAD+ together.

What about NAD+ injections?

That's a different route. NAD+ injections are compounded prescriptions, not supplements, with their own evidence and price questions. See NAD+ for the prescription side. If your real goal is steadier energy, the energy shortlist or the 30-second match will get you to options faster.

Frequently asked

Is NMN or NR better?
In the one head-to-head trial, they raised blood NAD+ about equally over 14 days. NR has more years of US regulatory history; NMN has newer trials in older adults. Neither has shown an anti-aging benefit.
Can you take NMN and NR together?
No trial has tested the combination, so there's no evidence it adds anything. Our page on taking NR and NMN together covers what's known.
Which is better, NMN or NMNH?
There's nothing to compare yet. A PubMed search turned up no clinical trial of NMNH, the reduced form of NMN, in people.
Is NR FDA approved?
No. It's a supplement and food ingredient. In 2016 FDA said it had no questions about a company's conclusion that NR is generally recognized as safe for use in foods, which isn't a drug approval.
Does NR or NMN slow aging?
Neither has been shown to slow aging in people. Trials have been short and mostly measured NAD+ levels and metabolic markers.

Sources

  1. [1] Christen S. The differential impact of three different NAD(+) boosters on circulatory NAD and microbial metabolism in humans (2026). PMID 41540253
  2. [2] Martens CR. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD(+) in healthy middle-aged and older adults (2018). PMID 29599478
  3. [3] Dollerup OL. A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects (2018). PMID 29992272
  4. [4] Yoshino M. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women (2021). PMID 33888596
  5. [5] Yi L. The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial (2023). PMID 36482258
  6. [6] Morifuji M. Ingestion of β-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults in a double-blind randomized, placebo-controlled study (2024). PMID 38789831
  7. [7] Pencina KM. MIB-626, an Oral Formulation of a Microcrystalline Unique Polymorph of β-Nicotinamide Mononucleotide, Increases Circulating Nicotinamide Adenine Dinucleotide and its Metabolome in Middle-Aged and Older Adults (2023). PMID 35182418
  8. [8] FDA agency response letter, GRAS Notice No. GRN 000635 (nicotinamide riboside chloride), August 3, 2016. FDA
  9. [9] FDA response to citizen petition on NMN, docket FDA-2023-P-0872 (September 29, 2025) (2025). FDA

Related research